Clay B. Siegall, President and CEO at Immunome Inc. (IMNM), bought 200,000 shares at $13.91 ($2.8M) on 2024-05-20, disclosed to the SEC on 2024-05-21.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.91 | 79,566 | $1.1M | 39.9% |
| 2 | $13.91 | 79,566 | $1.1M | 39.9% |
| 3 | $13.78 | 20,434 | $282K | 10.1% |
| 4 | $13.78 | 20,434 | $282K | 10.1% |
| Total | $13.88 avg | 200,000 | $2.8M | 100% |
| Filing → |
| IMNM | BUY | 2025-12-30 | $200K | — | Filing → |
| IMNM | BUY | 2025-12-22 | $298K | — | Filing → |
| IMNM | BUY | 2025-12-18 | $2.0M | — | Filing → |